Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials

Volume: 24, Issue: 8, Pages: 1459 - 1459
Published: Apr 12, 2019
Abstract
Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest thanks to its medical applications. This compound showed efficacy as anti-seizure, antipsychotic, neuroprotective, antidepressant and anxiolytic. The neuroprotective activity appears linked to its excellent anti-inflammatory and antioxidant properties. The purpose of...
Paper Details
Title
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Published Date
Apr 12, 2019
Journal
Volume
24
Issue
8
Pages
1459 - 1459
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.